USANA Health Sciences Inc logo

USNA - USANA Health Sciences Inc Share Price

$100.69 -0.7  -0.7%

Last Trade - 08/03/21

Sector
Consumer Defensives
Size
Mid Cap
Market Cap £1.53bn
Enterprise Value £1.30bn
Revenue £819.8m
Position in Universe 2116th / 6647
Bullish
Bearish
Unlock USNA Revenue
Momentum
Relative Strength (%)
1m +25.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -1.16%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 02nd Jan 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
918.5 1,006 1,047 1,189 1,061 1,135 1,190 1,176 +4.3%
+28.3 +11.2 -6.1 +36.6 -14.0 +33.1 -0.25 -4.44
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 02 January 2021, USANAHealth Sciences, Inc. revenues increased 7% to $1.13B. Netincome increased 24% to $124.7M. Revenues reflect SouthEast/Asia Pacific segment increase of 22% to $269.6M, NorthAsia segment increase of 20% to $115M. Net income benefitedfrom Selling/General/Admin. Expense decrease of 3% to$250.6M (expense). Basic Earnings per Share excludingExtraordinary Items increased from $4.44 to $5.89.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for USNA
Graphical History

Revenue

USNA Revenue Unlock USNA Revenue

Net Income

USNA Net Income Unlock USNA Revenue

Normalised EPS

USNA Normalised EPS Unlock USNA Revenue

PE Ratio Range

USNA PE Ratio Range Unlock USNA Revenue

Dividend Yield Range

USNA Dividend Yield Range Unlock USNA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
USNA EPS Forecasts Unlock USNA Revenue
Profile Summary

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Directors
Last Annual January 2nd, 2021
Last Interim January 2nd, 2021
Incorporated July 20, 1992
Public Since October 28, 1993
No. of Shareholders: 254
No. of Employees: 1,943
Sector Consumer Defensives
Industry Personal & Household Products & Services
Index
Exchange New York Stock Exchange
Shares in Issue 20,852,268
Free Float (0.0%)
Eligible for
ISAs
SIPPs
USNA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for USNA
Upcoming Events for USNA
Monday 19th April, 2021 Estimate
Q1 2021 USANA Health Sciences Inc Earnings Release
Frequently Asked Questions for USANA Health Sciences Inc
What is the USANA Health Sciences Inc share price?

As of 08/03/21, shares in USANA Health Sciences Inc are trading at $100.69, giving the company a market capitalisation of £1.53bn. This share price information is delayed by 15 minutes.

How has the USANA Health Sciences Inc share price performed this year?

Shares in USANA Health Sciences Inc are currently trading at $100.69 and the price has moved by 39.08% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the USANA Health Sciences Inc price has moved by 9.7% over the past year.

What are the analyst and broker recommendations for USANA Health Sciences Inc?

Of the analysts with advisory recommendations for USANA Health Sciences Inc, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for USANA Health Sciences Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will USANA Health Sciences Inc next release its financial results?

USANA Health Sciences Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-01-02
What is the USANA Health Sciences Inc dividend yield?

USANA Health Sciences Inc does not currently pay a dividend.

Does USANA Health Sciences Inc pay a dividend?

USANA Health Sciences Inc does not currently pay a dividend.

When does USANA Health Sciences Inc next pay dividends?

USANA Health Sciences Inc does not currently pay a dividend.

How do I buy USANA Health Sciences Inc shares?

To buy shares in USANA Health Sciences Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of USANA Health Sciences Inc?

Shares in USANA Health Sciences Inc are currently trading at $100.69, giving the company a market capitalisation of £1.53bn.

Where are USANA Health Sciences Inc shares listed? Where are USANA Health Sciences Inc shares listed?

Here are the trading details for USANA Health Sciences Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: USNA
What kind of share is USANA Health Sciences Inc?

Based on an overall assessment of its quality, value and momentum, USANA Health Sciences Inc is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a USANA Health Sciences Inc share price forecast 2021?

Shares in USANA Health Sciences Inc are currently priced at $100.69. At that level they are trading at 1.37% premium to the analyst consensus target price of 0.00.

Analysts covering USANA Health Sciences Inc currently have a consensus Earnings Per Share (EPS) forecast of 5.85 for the next financial year.

How can I tell whether the USANA Health Sciences Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like USANA Health Sciences Inc. Over the past six months, the relative strength of its shares against the market has been 19.02%. At the current price of $100.69, shares in USANA Health Sciences Inc are trading at 25.22% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the USANA Health Sciences Inc PE Ratio?

The USANA Health Sciences Inc PE ratio based on its reported earnings over the past 12 months is 17.29. The shares are currently trading at $100.69.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of USANA Health Sciences Inc?

USANA Health Sciences Inc's management team is headed by:

Gilbert Fuller - LED
Robert Anciaux - DRC
Kevin Guest - CHM
G Hekking - CFO
Daniel Macuga - CMO
Jim Brown - PRE
Paul Jones - OTH
Feng Peng - IND
David Mulham - OTH
Robert Sinnott - CSO
Walter Noot - COO
Peggie Pelosi - IND
P. Joshua Foukas - GCN
Brent Neidig - MDR
John Fleming - DRC
Who are the major shareholders of USANA Health Sciences Inc?

Here are the top five shareholders of USANA Health Sciences Inc based on the size of their shareholding:

Gull Global, Ltd. Corporation
Percentage owned: 40.69% (8.49m shares)
Renaissance Technologies LLC Hedge Fund
Percentage owned: 8.26% (1.72m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 8.14% (1.70m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 6.85% (1.43m shares)
iShares Core S&P Small-Cap ETF Mutual Fund
Percentage owned: 3.85% (803k shares)
Similar to USNA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.